{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:05:14Z","timestamp":1793390714213,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s40120-021-00285-w","type":"journal-article","created":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T09:02:41Z","timestamp":1634979761000},"page":"1103-1125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["The Lived Experience of Myasthenia Gravis: A Patient-Led Analysis"],"prefix":"10.1007","volume":"10","author":[{"given":"Nancy","family":"Law","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Davio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Blunck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Lobban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenza","family":"Seddik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,23]]},"reference":[{"key":"285_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/s1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ. Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14:1023\u201336. https:\/\/doi.org\/10.1016\/s1474-4422(15)00145-3.","journal-title":"Lancet Neurol"},{"key":"285_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010;10:46. https:\/\/doi.org\/10.1186\/1471-2377-10-46.","journal-title":"BMC Neurol"},{"key":"285_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1819","volume":"10","author":"E Westerberg","year":"2020","unstructured":"Westerberg E, Punga AR. Epidemiology of myasthenia gravis in Sweden 2006\u20132016. Brain Behav. 2020;10: e01819. https:\/\/doi.org\/10.1002\/brb3.1819.","journal-title":"Brain Behav"},{"key":"285_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","volume":"5","author":"NE Gilhus","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren J. Myasthenia gravis. Nat Rev Dis Primers. 2019;5:30. https:\/\/doi.org\/10.1038\/s41572-019-0079-y.","journal-title":"Nat Rev Dis Primers"},{"key":"285_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.nmd.2020.06.010","volume":"30","author":"AM Ruiter","year":"2020","unstructured":"Ruiter AM, Verschuuren J, Tannemaat MR. Fatigue in patients with myasthenia gravis. A systematic review of the literature. Neuromuscul Disord. 2020;30:631\u20139. https:\/\/doi.org\/10.1016\/j.nmd.2020.06.010.","journal-title":"Neuromuscul Disord"},{"key":"285_CR6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9760","volume":"12","author":"C Hogan","year":"2020","unstructured":"Hogan C, Lee J, Sleigh BC, Banerjee PR, Ganti L. Acute myasthenia crisis: a critical emergency department differential. Cureus. 2020;12: e9760. https:\/\/doi.org\/10.7759\/cureus.9760.","journal-title":"Cureus"},{"key":"285_CR7","doi-asserted-by":"publisher","DOI":"10.4172\/2155-9562.1000317","author":"BC Diaz","year":"2015","unstructured":"Diaz BC, Flores-Gavil\u00e1n P, Garc\u00eda-Ramos G, Lorenzana-Mendoza NA. Myasthenia gravis and its comorbidities. J Neurol Neurophysiol. 2015. https:\/\/doi.org\/10.4172\/2155-9562.1000317.","journal-title":"J Neurol Neurophysiol."},{"key":"285_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3889\/oamjms.2018.110","volume":"6","author":"N Tanovska","year":"2018","unstructured":"Tanovska N, Novotni G, Sazdova-Burneska S, et al. Myasthenia gravis and associated diseases. Open Access Maced J Med Sci. 2018;6:472\u20138. https:\/\/doi.org\/10.3889\/oamjms.2018.110.","journal-title":"Open Access Maced J Med Sci"},{"key":"285_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/wnl.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016;87:419\u201325. https:\/\/doi.org\/10.1212\/wnl.0000000000002790.","journal-title":"Neurology"},{"key":"285_CR10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13023-018-0936-x","volume":"13","author":"P Kaufmann","year":"2018","unstructured":"Kaufmann P, Pariser AR, Austin C. From scientific discovery to treatments for rare diseases\u2014the view from the National Center for Advancing Translational Sciences\u2014Office of Rare Diseases Research. Orphanet J Rare Dis. 2018;13:196. https:\/\/doi.org\/10.1186\/s13023-018-0936-x.","journal-title":"Orphanet J Rare Dis"},{"key":"285_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5152\/eurasianjmed.2017.17009","volume":"49","author":"Y Aydin","year":"2017","unstructured":"Aydin Y, Ulas AB, Mutlu V, Colak A, Eroglu A. Thymectomy in myasthenia gravis. Eurasian J Med. 2017;49:48\u201352. https:\/\/doi.org\/10.5152\/eurasianjmed.2017.17009.","journal-title":"Eurasian J Med"},{"key":"285_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102712","volume":"20","author":"AM Lascano","year":"2021","unstructured":"Lascano AM, Lalive PH. Update in immunosuppressive therapy of myasthenia gravis. Autoimmun Rev. 2021;20: 102712. https:\/\/doi.org\/10.1016\/j.autrev.2020.102712.","journal-title":"Autoimmun Rev"},{"key":"285_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s40037-019-0509-2","volume":"8","author":"BE Neubauer","year":"2019","unstructured":"Neubauer BE, Witkop CT, Varpio L. How phenomenology can help us learn from the experiences of others. Perspect Med Educ. 2019;8:90\u20137. https:\/\/doi.org\/10.1007\/s40037-019-0509-2.","journal-title":"Perspect Med Educ"},{"key":"285_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11017-010-9161-x","volume":"32","author":"H Carel","year":"2011","unstructured":"Carel H. Phenomenology and its application in medicine. Theor Med Bioeth. 2011;32:33\u201346. https:\/\/doi.org\/10.1007\/s11017-010-9161-x.","journal-title":"Theor Med Bioeth"},{"key":"285_CR15","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/jmp\/jhz013","volume":"44","author":"F Svenaeus","year":"2019","unstructured":"Svenaeus F. A defense of the phenomenological account of health and illness. J Med Philos. 2019;44:459\u201378. https:\/\/doi.org\/10.1093\/jmp\/jhz013.","journal-title":"J Med Philos"},{"key":"285_CR16","unstructured":"European Medicines Agency. Patients and consumers. https:\/\/www.ema.europa.eu\/en\/partners-networks\/patients-consumers. Accessed 17 Feb 2021."},{"key":"285_CR17","unstructured":"US Food & Drug Administration. Patient listening sessions. 2020. https:\/\/www.fda.gov\/patients\/learn-about-fda-patient-engagement\/patient-listening-sessions. Accessed 17 Feb 2021."},{"key":"285_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/1049732315570116","volume":"25","author":"L Garrino","year":"2015","unstructured":"Garrino L, Picco E, Finiguerra I, Rossi D, Simone P, Roccatello D. Living with and treating rare diseases: experiences of patients and professional health care providers. Qual Health Res. 2015;25:636\u201351. https:\/\/doi.org\/10.1177\/1049732315570116.","journal-title":"Qual Health Res"},{"key":"285_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1547-5069.2001.00021.x","volume":"33","author":"BL Paterson","year":"2001","unstructured":"Paterson BL. The shifting perspectives model of chronic illness. J Nurs Scholarsh. 2001;33:21\u20136. https:\/\/doi.org\/10.1111\/j.1547-5069.2001.00021.x.","journal-title":"J Nurs Scholarsh"},{"key":"285_CR20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10072-016-2556-3","volume":"37","author":"D Cioncoloni","year":"2016","unstructured":"Cioncoloni D, Casali S, Ginanneschi F, et al. Major motor-functional determinants associated with poor self-reported health-related quality of life in myasthenia gravis patients. Neurol Sci. 2016;37:717\u201323. https:\/\/doi.org\/10.1007\/s10072-016-2556-3.","journal-title":"Neurol Sci"},{"key":"285_CR21","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1097\/JNN.0b013e31828291a6","volume":"45","author":"YT Chen","year":"2013","unstructured":"Chen YT, Shih FJ, Hayter M, Hou CC, Yeh JH. Experiences of living with myasthenia gravis: a qualitative study with Taiwanese people. J Neurosci Nurs. 2013;45:E3-10. https:\/\/doi.org\/10.1097\/JNN.0b013e31828291a6.","journal-title":"J Neurosci Nurs"},{"key":"285_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013278","volume":"7","author":"Y Nagane","year":"2017","unstructured":"Nagane Y, Murai H, Imai T, et al. Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study. BMJ Open. 2017;7: e013278. https:\/\/doi.org\/10.1136\/bmjopen-2016-013278.","journal-title":"BMJ Open"},{"key":"285_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12883-016-0757-2","volume":"16","author":"A Frost","year":"2016","unstructured":"Frost A, Svendsen ML, Rahbek J, Stapelfeldt CM, Nielsen CV, Lund T. Labour market participation and sick leave among patients diagnosed with myasthenia gravis in Denmark 1997\u20132011: a Danish nationwide cohort study. BMC Neurol. 2016;16:224. https:\/\/doi.org\/10.1186\/s12883-016-0757-2.","journal-title":"BMC Neurol"},{"key":"285_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/CND.0b013e3180316324","volume":"8","author":"SB Stewart","year":"2007","unstructured":"Stewart SB, Robertson KR, Johnson KM, Howard JF Jr. The prevalence of depression in myasthenia gravis. J Clin Neuromuscul Dis. 2007;8:111\u20135. https:\/\/doi.org\/10.1097\/CND.0b013e3180316324.","journal-title":"J Clin Neuromuscul Dis"},{"key":"285_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jocn.2018.01.011","volume":"50","author":"NFT Braz","year":"2018","unstructured":"Braz NFT, Rocha NP, Vieira \u00c9LM, et al. Muscle strength and psychiatric symptoms influence health-related quality of life in patients with myasthenia gravis. J Clin Neurosci. 2018;50:41\u20134. https:\/\/doi.org\/10.1016\/j.jocn.2018.01.011.","journal-title":"J Clin Neurosci"},{"key":"285_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.21307\/ajon-2017-112","volume":"25","author":"T Keer-Keer","year":"2015","unstructured":"Keer-Keer T. The lived experience of adults with myasthenia gravis: a phenomenological study. AJON. 2015;25:40\u20136. https:\/\/doi.org\/10.21307\/ajon-2017-112.","journal-title":"AJON."},{"key":"285_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1477-7525-6-13","volume":"6","author":"SD Mathias","year":"2008","unstructured":"Mathias SD, Gao SK, Miller KL, et al. Impact of chronic immune thrombocytopenic purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes. 2008;6:13. https:\/\/doi.org\/10.1186\/1477-7525-6-13.","journal-title":"Health Qual Life Outcomes"},{"key":"285_CR28","unstructured":"American Diabetes Association. Therapeutic inertia\u2014a brief discussion and definition. https:\/\/professional.diabetes.org\/meetings\/defining-therapeutic-inertia. Accessed 24 Mar 2021."},{"key":"285_CR29","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/mus.26695","volume":"60","author":"G Cutter","year":"2019","unstructured":"Cutter G, Xin H, Aban I, et al. Cross-sectional analysis of the Myasthenia Gravis Patient Registry: disability and treatment. Muscle Nerve. 2019;60:707\u201315. https:\/\/doi.org\/10.1002\/mus.26695.","journal-title":"Muscle Nerve"},{"key":"285_CR30","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1177\/1049732318796831","volume":"28","author":"H van der Meide","year":"2018","unstructured":"van der Meide H, Teunissen T, Collard P, Visse M, Visser LH. The mindful body: a phenomenology of the body with multiple sclerosis. Qual Health Res. 2018;28:2239\u201349. https:\/\/doi.org\/10.1177\/1049732318796831.","journal-title":"Qual Health Res"},{"key":"285_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098089","volume":"9","author":"C Barnett","year":"2014","unstructured":"Barnett C, Bril V, Kapral M, Kulkarni A, Davis AM. A conceptual framework for evaluating impairments in myasthenia gravis. PLoS ONE. 2014;9: e98089. https:\/\/doi.org\/10.1371\/journal.pone.0098089.","journal-title":"PLoS ONE"},{"key":"285_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/mus.24556","volume":"52","author":"S Ohlraun","year":"2015","unstructured":"Ohlraun S, Hoffmann S, Klehmet J, et al. Impact of myasthenia gravis on family planning: how do women with myasthenia gravis decide and why? Muscle Nerve. 2015;52:371\u20139. https:\/\/doi.org\/10.1002\/mus.24556.","journal-title":"Muscle Nerve"},{"key":"285_CR33","doi-asserted-by":"publisher","first-page":"e1617","DOI":"10.1212\/wnl.0000000000010574","volume":"95","author":"M Mendoza","year":"2020","unstructured":"Mendoza M, Tran C, Bril V, Katzberg HD, Barnett C. Patient-acceptable symptom states in myasthenia gravis. Neurology. 2020;95:e1617\u201328. https:\/\/doi.org\/10.1212\/wnl.0000000000010574.","journal-title":"Neurology"},{"key":"285_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12883-019-1573-2","volume":"19","author":"ED Bacci","year":"2019","unstructured":"Bacci ED, Coyne KS, Poon JL, Harris L, Boscoe AN. Understanding side effects of therapy for myasthenia gravis and their impact on daily life. BMC Neurol. 2019;19:335. https:\/\/doi.org\/10.1186\/s12883-019-1573-2.","journal-title":"BMC Neurol"},{"key":"285_CR35","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jns.2016.08.057","volume":"369","author":"L Gotterer","year":"2016","unstructured":"Gotterer L, Li Y. Maintenance immunosuppression in myasthenia gravis. J Neurol Sci. 2016;369:294\u2013302. https:\/\/doi.org\/10.1016\/j.jns.2016.08.057.","journal-title":"J Neurol Sci"},{"key":"285_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/mus.26069","volume":"58","author":"C Tran","year":"2018","unstructured":"Tran C, Bril V, Katzberg HD, Barnett C. Fatigue is a relevant outcome in patients with myasthenia gravis. Muscle Nerve. 2018;58:197\u2013203. https:\/\/doi.org\/10.1002\/mus.26069.","journal-title":"Muscle Nerve"},{"key":"285_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.538","volume":"6","author":"S Hoffmann","year":"2016","unstructured":"Hoffmann S, Ramm J, Grittner U, Kohler S, Siedler J, Meisel A. Fatigue in myasthenia gravis: risk factors and impact on quality of life. Brain Behav. 2016;6: e00538. https:\/\/doi.org\/10.1002\/brb3.538.","journal-title":"Brain Behav"},{"key":"285_CR38","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1177\/104973299129122289","volume":"9","author":"B Paterson","year":"1999","unstructured":"Paterson B, Thorne S, Crawford J, Tarko M. Living with diabetes as a transformational experience. Qual Health Res. 1999;9:786\u2013802. https:\/\/doi.org\/10.1177\/104973299129122289.","journal-title":"Qual Health Res"},{"key":"285_CR39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1348\/135910708x332936","volume":"14","author":"K Hefferon","year":"2009","unstructured":"Hefferon K, Grealy M, Mutrie N. Post-traumatic growth and life threatening physical illness: a systematic review of the qualitative literature. Br J Health Psychol. 2009;14:343\u201378. https:\/\/doi.org\/10.1348\/135910708x332936.","journal-title":"Br J Health Psychol"},{"key":"285_CR40","first-page":"56","volume":"38","author":"WJ Koopman","year":"2016","unstructured":"Koopman WJ, LeBlanc N, Fowler S, Nicolle MW, Hulley D. Hope, coping, and quality of life in adults with myasthenia gravis. Can J Neurosci Nurs. 2016;38:56\u201364.","journal-title":"Can J Neurosci Nurs"},{"key":"285_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pec.2013.02.002","volume":"92","author":"G Embuldeniya","year":"2013","unstructured":"Embuldeniya G, Veinot P, Bell E, et al. The experience and impact of chronic disease peer support interventions: a qualitative synthesis. Patient Educ Couns. 2013;92:3\u201312. https:\/\/doi.org\/10.1016\/j.pec.2013.02.002.","journal-title":"Patient Educ Couns"},{"key":"285_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2288-8-45","volume":"8","author":"J Thomas","year":"2008","unstructured":"Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8:45. https:\/\/doi.org\/10.1186\/1471-2288-8-45.","journal-title":"BMC Med Res Methodol"},{"key":"285_CR43","doi-asserted-by":"publisher","first-page":"175628641983224","DOI":"10.1177\/1756286419832242","volume":"12","author":"C Schneider-Gold","year":"2019","unstructured":"Schneider-Gold C, Hagenacker T, Melzer N, Ruck T. Understanding the burden of refractory myasthenia gravis. Ther Adv Neurol Disord. 2019;12:1756286419832242. https:\/\/doi.org\/10.1177\/1756286419832242.","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-021-00285-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-021-00285-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-021-00285-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T13:20:51Z","timestamp":1646400051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-021-00285-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,23]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["285"],"URL":"https:\/\/doi.org\/10.1007\/s40120-021-00285-w","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,23]]},"assertion":[{"value":"10 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this article was revised to include a peer-reviewed video retrospectively and to include the Digital Features text.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}